Low Dose of Diltiazem for Rate Control of Atrial Fibrillation
Information source: Seoul National University Hospital
Information obtained from ClinicalTrials.gov on October 19, 2009
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Atrial Fibrillation
Intervention: low dose diltiazem (Drug)
Phase: Phase 4
Status: Recruiting
Sponsored by: Seoul National University Hospital Overall contact:
Kyuseok Kim, Phone: +82-31-787-3049, Email: dremkks@snubh.org
Summary
This study is to show the efficacy and safety of low dose diltiazem for the treatment of
atrial fibrillation with rapid ventricular response in emergency room. We will compare the
standard dose of diltiazem(0. 25mg/kg) with low dose diltiazem(0. 1mg/kg).
Clinical Details
Study design: Treatment, Randomized, Double Blind (Subject, Investigator, Outcomes Assessor), Dose Comparison, Parallel Assignment, Safety/Efficacy Study
Primary outcome: Success rate of rate control
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- atrial fibrillation with rapid ventricular response in emergency room
Exclusion Criteria:
- age<18
- systolic blood pressure<90mmHg
- no consent
Locations and Contacts
Kyuseok Kim, Phone: +82-31-787-3049, Email: dremkks@snubh.org
Seoul National University Hospital, Seoul, Korea, Republic of; Recruiting
Sang Hoon , MD, PhD, Phone: +82-2-2072-3047, Email: nasanghoon@gmail.com
Additional Information
Starting date: August 2009
Ending date: August 2011
Last updated: September 20, 2009
|
